These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10831268)
1. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension. Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats. Lee FY; Chu CJ; Wang SS; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD Eur J Clin Invest; 2001 Feb; 31(2):145-53. PubMed ID: 11168453 [TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension. Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372 [TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension. Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050 [TBL] [Abstract][Full Text] [Related]
5. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773 [TBL] [Abstract][Full Text] [Related]
6. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin. Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats. Huang HC; Wang SS; Chen YC; Lee FY; Chang FY; Lin HC; Hou MC; Chan CC; Chen CT; Wu SL; Lee SD Eur J Clin Invest; 2003 Jun; 33(6):505-12. PubMed ID: 12795648 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension. Huang HC; Chen YC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Wu SL; Lee SD J Chin Med Assoc; 2004 Jun; 67(6):268-74. PubMed ID: 15366403 [TBL] [Abstract][Full Text] [Related]
9. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage. Lee FY; Wang SS; Tsai MH; Huang HC; Lin HC; Lee SD PLoS One; 2014; 9(3):e92093. PubMed ID: 24633079 [TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Xu J; Cao H; Liu H; Wu ZY Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497 [TBL] [Abstract][Full Text] [Related]
11. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Bernadich C; Bandi JC; Melin P; Bosch J Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630 [TBL] [Abstract][Full Text] [Related]
12. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats. Moreau R; Cailmail S; Valla D; Lebrec D Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen. Yang YY; Lin HC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD J Hepatol; 2005 May; 42(5):652-8. PubMed ID: 15826713 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension. Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514 [TBL] [Abstract][Full Text] [Related]
15. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats. Heinemann A; Stauber RE J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats. Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats. Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725 [TBL] [Abstract][Full Text] [Related]
19. Time profile of the haemodynamic effects of terlipressin in portal hypertension. Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670 [TBL] [Abstract][Full Text] [Related]
20. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats. Wu ZY; Chen XS; Qiu JF; Cao H World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]